Progressive Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.41M Sell
11,000
-20
-0.2% -$10.9K 1.43% 23
2025
Q4
$6.39M Sell
11,020
-100
-0.9% -$56.5K 1.53% 24
2025
Q3
$5.39M Sell
11,120
-149
-1% -$69.4K 1.31% 25
2025
Q2
$4.57M Sell
11,269
-134
-1% -$56K 1.16% 24
2025
Q1
$5.67M Sell
11,403
-201
-2% -$109K 1.59% 21
2024
Q4
$6.04M Sell
11,604
-348
-3% -$191K 1.55% 22
2024
Q3
$7.39M Sell
11,952
-152
-1% -$90K 1.9% 22
2024
Q2
$6.69M Sell
12,104
-238
-2% -$136K 1.77% 21
2024
Q1
$7.17M Sell
12,342
-165
-1% -$92.6K 1.97% 23
2023
Q4
$6.64M Sell
12,507
-64
-0.5% -$31K 1.89% 23
2023
Q3
$6.36M Sell
12,571
-126
-1% -$67.1K 2.07% 22
2023
Q2
$6.62M Sell
12,697
-147
-1% -$79.3K 2.07% 21
2023
Q1
$7.4M Buy
+12,844
New +$7.24M 2.39% 19

Other funds holding TMO

Progressive Investment Management's TMO Position: Q1 2026 in Review

Progressive Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 0.18% in Q1 2026, selling an estimated $10.9K and leaving 11,000 shares worth $5.41M. The position accounts for 1.43% of the portfolio, ranked #23.

Progressive Investment Management first reported a position in TMO in Q1 2023 and has held it in 13 quarters since. The position peaked at $7.4M in Q1 2023. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Progressive Investment Management held 11,000 shares of Thermo Fisher Scientific worth $5.41M as of Q1 2026.
  • Progressive Investment Management sold 20 Thermo Fisher Scientific shares in Q1 2026, an estimated $10.9K.
  • Thermo Fisher Scientific made up 1.43% of Progressive Investment Management's portfolio in Q1 2026, its #23 holding.
  • Progressive Investment Management first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 13 quarters since.
  • Progressive Investment Management's Thermo Fisher Scientific position peaked at $7.4M in Q1 2023.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Progressive Investment Management's 13F filing for Q1 2026, filed 5 May 2026.